Latent Clinical Outcomes of Appropriate and Inappropriate ICD Shocks

Year 2014, Volume: 17 Issue: 3, 167 - 171, 01.03.2013

Efe Edem Mustafa Ozan Gürsoy Mustafa Türker Pabuccu Sedat Taş Yusuf Can Ümit İlker Tekin Ahmet Ozan Kınay Mehmet Akif Çakar Özgür Aslan Hüseyin Gündüz

Abstract

Introduction: Despite the proven survival benefits, ICD (implantable cardioverter defibrillator) therapy has still some drawbacks. It is clearly known that inappropriate shocks increase mortality however, randomized controlled trials showed us that appropriate shocks might also increase mortality. Left untreated, ventricular arrhythmias are known to be fatal and in this case ICD shock therapy is life-saving so it is appropriate to assess the effects of ATP (Antitachycardial Pacing) therapy and shock separately. The aim of our study is to determine the effects of inappropriate and appropriate shocks in a population of ICD implanted patients.Patients and Methods: We retrospectively screened ICD implanted patients between January 2003 and December 2013 in our department. Additionally, patients were called by telephone and parameters such as survival and rehospitalization were updated. During the retrospective follow-up, the occurrence of inappropriate-appropriate ICD shocks and mortality causes were noted. Characteristics of patients suffering from shocks were also investigated. Results: A total of 260 ICD implanted patients were included in the study. 40 of them experienced inappropriate shocks (defined as at least one inappropriate shock, not any appropriate shocks). 69 patients experienced appropriate shocks (defined as at least one appropriate shock, not inoppropriate shocks). Retrospective mean follow up period was 49 months, minimum follow up period was 6 months. Among 40 patients experiencing inappropriate shocks 13 deaths (32.5%) occured (p=0.039). Among 69 patients experiencing appropriate shocks 24 deaths (34.8%) occured (p=0.001).Conclusion: In a large cohort of ICD patients, inappropriate and appropriate shocks were common. The most important finding was the association between appropriate shocks and mortality.

Keywords

Implantable Cardioverter-Defibrillators, Heart Failure, Cardiac Arrhythmias

Uygun ve Uygunsuz ICD Şoklamalarının Latent Klinik Sonuçları

Abstract

Giriş: Kanıtlanmış faydalarına rağmen, ICD (implantable cardioverter defibrillator) tedavisinin halen bazı dezavantajları bulunmaktadır. Net olarak bilinmektedir ki, uygunsuz ICD şoklamaları mortaliteyi arttırmaktadır ancak randomize kontrollü klinik çalışmalar bize aynı zamanda uygun şoklamaların da mortaliteyi arttırabildiğini göstermiştir. Tedavi edilmediği takdirde ventriküler aritmiler ölümcüldür ve bu durumda ICD tedavisinin yaşam kurtarıcı olduğu bilinmektedir. Bu nedenle ATP (Antitachycardial Pacing) ve şoklama terapilerinin etkilerini ayrı ayrı değerlendirmek uygun olacaktır. Çalışmamızın amacı ICD implante edilmiş olan bir grup hastada uygun ve uygunsuz ICD şoklamalarının oluşturdukları klinik sonuçların saptanmasıdır.Hastalar ve Yöntem: Retrospektif olarak kliniğimizde Ocak 2003 ve Aralık 2013 tarihleri arasında ICD implante edilmiş olan hastaları tarandı. Ek olarak, bahsi geçen hastalar telefon ile arandı ve sağkalım, tekrarlayan hastaneye yatış gibi parametreler güncellendi. Retrospektif tarama sırasında uygun-uygunsuz şoklamaların varlığı ve mortalite nedenleri not edildi. Şoklama yaşayan hastaların özellikleri dikkatli bir şekilde araştırıldı. Bulgular: Çalışmaya toplamda 260 hasta dahil edildi. 40 tanesinde uygunsuz şoklama (uygun şoklama olmaksızın en az bir adet uygunsuz şoklama) ve 69 tanesinde uygun şoklama (uygunsuz şoklama olmaksızın en az bir adet uygun şoklama) saptandı. Retrospektif ortalama takip süresi 49 ay, minimum takip süresi 6 ay idi. Uygunsuz şoklama yaşayan 40 hastadan 13 tanesi (%32.5) exitus oldu (p=0.039). Uygun şoklama yaşayan 69 hastadan 24 tanesi (%34.8) exitus oldu (p=0.001).Sonuç: Geniş bir ICD implante edilmiş hasta serisinde, uygun ve uygunsuz ICD şoklamaları yaygın olarak izlendi. En önemli bulgu uygun şoklamalar ve mortalite arasında izlenen kuvvetli ilişki idi.

Keywords

İmplante Edilebilir Kardiovertör-Defibrilatörler, Kalp Yetmezliği, Kardiak Aritmiler

References

• Stevenson WG, Chaitman BR, Ellenbogen KA, Epstein AE, Gross WL, Hayes DL, et al. Clinical assessment and management of patients with implanted cardioverter-defibrillators presenting to nonelectrophysiologists. Circulation 2004;110:3866-9.
• Mirowski M, Reid PR, Mower MM, Watkins L, Gott VL, Schauble JF, et al. Termination of malignant ventricular arrhytmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980;303:322-4.
• Van Rees JB, Borleffs CJ, de Bie MK, Stijnen T, van Evren L, Bax JJ, et al. Inappropriate Implantable cardioverter-defibrillator shocks: Incidence, Predictors, and Impact on Mortality. J Am Coll Cardiol 2011;57:556-62.
• Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, Daubert JP, et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 2004;110:3760-5.
• Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, et al. Prognostic Importance of defibrillator shocks in patients with heart failure. N Eng J Med 2008;359:1009-17.
• Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved Survival with an implanted defibrillator in patients with coronary heart disease at high risk for ventricular arrhytmia. N Engl J Med 1996;335;1933-40.
• Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomised study of the prevention of sudden death in patients with coronary heart disease. N Engl J Med 1999;341;1882-90.
• Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346;877-83.
• Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Sudden Cardiac Death in Heart Failure (SCD-HeFT) Investigators. Amiodarone or an implanted cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352;225-37.
• Sweeney MO, Sherfesee L, DeGroot PJ, Wathen MS, Wilkoff BL. Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. Heart Rhythm 2010;7:353-60.
• Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, et al. Cardiac Re-synchronization Therapy for the Prevention of Heart-Failure Events. N Engl J Med 2009;361:1329-38.
• Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, et al. Prophylactic use of an implantable cardioverter defibrillator after acute myocardial infarction N Engl J Med 2004;351:2481-8.